The 21-aminosteroid U-74389F attenuates hyperexpression of GAP-43 and NADPH-diaphorase in the spinal cord of wobbler mouse, a model for amyotrophic lateral sclerosis

Neurochemical Research

Volumn 24, Issue 1, 1999, Pages 1-8

  González Deniselle, Maria Claudia ^a   González, Susana L ^a   Lima, Analia E ^a   Wilkin, Graham ^b   De Nicola, Alejandro F ^a,c  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c Argentina   (Argentina)

Author keywords

21 aminosteroids; GAP 43; NADPH diaphorase; Neurogeneration; Wobbler mouse

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; 21 AMINOSTEROID; NEUROMODULIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; GLIA CELL; IMMUNOCYTOCHEMISTRY; MOTONEURON; MOUSE; NERVE FIBER REGENERATION; NERVE SPROUTING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTIOXIDANTS; DIHYDROLIPOAMIDE DEHYDROGENASE; DISEASE MODELS, ANIMAL; FEMALE; GAP-43 PROTEIN; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, NEUROLOGIC MUTANTS; MOTOR NEURONS; PREGNATRIENES; SPINAL CORD;

ANIMALIA;

EID: 0343396819     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020918310281     Document Type: Article

References (54)

1. Duchen, L. W., Falconer, D. S., and Stricht, S. J. 1966. Hereditary progresive neurogeic muscular atrophy in the mouse. J. Physiol. (London) 183:53P-55P.
2. Mitsumoto, H., and Bradley, W. G. 1982. Murine motor neuron disease (the Wobbler mouse): degeneration and regeneration of the lower motor neuron. Brain Res. 105:811-834.
3. Leetsma, J. E. 1980. Animal model: Motor neuron disease in the wobbler (wr/wr) mouse. Am. J. Pathol. 100:811-814.
4. Ma, W., and Vacca-Galloway, L. L. 1982. Spiny interneurons identified in the normal mouse spinal cord shows alterations in the Wobbler mouse: a model for inherited motoeuron disease. Rest. Neurol. Neurosci. 4:381-392.
5. Ma, W., and Vacca-Galloway, L. L. 1991. Reduced branching and lenght of dendrites detected in cervical spial cord motoneurons of wobbler mouse, a model for inherited motoneuron disease. J. Comp. Neurol. 311:210-222.
6. Hantaz-Ambroise, D., Blondet, B., Murawsky, M., and Rieger, F. 1994. Abnormal astrocyte differentiation and defective cellular interactions in wobbler mouse spinal cord. J. Neurocytol. 23:179-192.
7. Gonzalez Deniselle, M. C., Gonzalez, S., Piroli, G., Lima, A., and De Nicola, A. F. 1996. The 21-aminosteroid U-74389F increases the number of glial fibrillary acidid protein-expressing astrocytes in the spinal cord of wobbler mice. Cell Mol. Neurobiol. 16:61-72.
8. Gonzalez Deniselle, M. C., Gonzalez, S., Piroli, G., Ferrini, M., Lima, A., and De Nicola, A. F. 1997. Glucocorticoid receptors and actions in the spinal cord of the wobbler mouse, a model for amyotrophic lateral sclerosis. J. Steroid Biochem. & Mol. Biol. 60:205-213.
9. González-Deniselle M. C., González S. L., Lima A., and De Nicola A. F. 1997. The antioxidant steroid U-74389F attenuates hyperexpression of GAP-43 in wobbler mouse, an animal model for amyotrophic lateral sclerosis (ALS). J. Neurol. Sci. 150:8139.
10. De Nicola, A. F. 1993. Steroid hormones and neuronal regeneration. Adv. Neurol. 59:199-206.
11. Braughler, J. M., and Hall, E. D. 1984. Effects of multidose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilamente degradation ad energy metabolism. J. Neurosurg. 61:290-295.
12. Hall, E. D. 1993. Neuroprotective actions of glucocorticoid and non-glucocorticoid steroids in acute neuronal injury. Cell. Mol. Neurobiol. 13:415-432.
13. Kupersmith, M. J., Kaufman, D., Paty, D. W., Ebers, G., McFarland, H., Johnson, K., Reingold, S., and Whitaker, J. 1994. Megadose corticosteroids in multiple sclerosis. Neurology 4:1-4.
14. Olanow, C. W. 1993. A radical hypothesis for neurodegeneration. TINS 16:439-444.
15. Bowling, A. C., Schulz, J. B., Brown, R. H., and Beal, M. F., 1993. Superoxide dismutase activity, oxidative damage and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61:2322-2325.
16. Abe, K., Morita, S., Kikuchi, T. Itoyama, Y. 1997. Protective effect of a novel free-radical scavenger, OPC-14117, on wobbler mouse motor neuron disease. J. Neurosci. Res. 48:63-70.
17. Ikeda, K., Kinoshita, M., Iwasaki, Y., Tagaya, N., and Shiojima, T. 1995. Lecithinized superoxide dismutase retards wobbler mouse motoneuron disease. Neuromusc. Disord. 5:383-390.
18. Henderson, J. T., Javaheri, M., Kopko, S., and Roder, J. C. 1996. Reduction of lower motor neuron degeneration in wobbler mice by n-acetyl-1-cysteine. J. Neurosci. 16:7574-7582.
19. Benowitz, L. I., and Routtenberg, A. 1997. GAP-43: an intrinsic determinant of neuronal development and plasticity. TINS 20:84-91.
20. Curtis, R., Averill, S., Priestley, J. V., and Wilkin, G. 1993. The distribution of GAP-43 in normal rat spinal cord. J. Neurocytol. 22:39-50.
21. Curtis, R., Green, D., Iindsay, R. m., and Wilkin, G. P. 1993. Up-regulation of GAP-43 and growth of axons in rat spinal cord after compression injury. J. Neurocytol. 22:51-64.
22. Popper, P., Farber, D. B., Micevych, P. E., Minoofar, K., and Bronstein, J. M. 1997. RTPM-2 expression and tunel staining in neurodegenerative diseases: studies in wobbler and rd mice. Exp. Neurol. 143:246-254.
23. Vizzard, M. A., Erdman, S. L., Roppolo, J. R., Forstermann, U., and de Groat, W. C. 1994. Differential localization of neuronal nitric oxide synthase immunoreactivity and NADPH-diaphorase activity in the cat spinal cord. Cell Tissue Res. 278:299-309.
24. Clowry, G. J., and McHanwell, S. 1996. Expression of nitric oxide synthase byt motor neurons in the spinal cord of the mutant mouse wobbler. Neurosci. Lett. 215:177-180.
25. Hess, D. T., Patterson, S. I., Smith, D. S., and Skene, J. H. P. 1993., Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature 366:562-565.
26. Yung, K. K. L., Tang, F., and Vacca-Galloway, L. L. 1992. Changes of neuropeptides in spinal cord and brain stem of Wobbler mouse at different stages of motoneuron disease. Neuroscience 50:209-222.
27. Coulpier, M., Junier, M-P., Peschanski, M., and Dreyfus, P. A. 1996. Bcl-2 sensitivity differentiates two pathways for motoneuronal death in the wobbler mutant mouse. J. Neurosci. 16:5897-5904.
28. Curtis, R., Hardy, R., Reynolds, R., Spruce, B. A., and Wilkin, G. 1991. Down-regulation of GAP-43 during oligodendrocyte development and lack of expression by astrocytes in vivo: implications for macroglial differentiation. Eur. J. Neurosci. 3:876-886.
29. Rexed, B. 1954. A cytoarchitectonic atlas of the spinal cord of the rat. J. Comp. Neurol. 100:297-380.
30. Ferrini, M., Lima, A., and De Nicola, A. F. 1995. Estradiol abolishes autologous regulation of glucocorticoid receptors in brain. Life Sci. 57:2403-2412.
31. Grillo, C., Piroli, G., Lima, A., McEwen, B. S., and De Nicola, A. F. 1997. Aldosterone up-regulates mRNA for the α3 and β1 isoforms of (Na,K)-ATPase in several brain regions from adrenalectomized rats. Brain Res. 767:120-127.
32. Mercken, M., Lubke, U., Vandermeeren, M., Gheuens, J., and Oestreicher, A. B. 1992. Immunocytochemical detection of the growth-associated protein B-50 by newly characterized monoclonal antibodies in human brain and muscle. J. Neurobiol. 23:309-321.
33. Stewart, H. J. S., Cowen, T., Curtis, R., Wilkin, G. P., Mirsky, R., and Jessen, K. R. 1992. GAP-43 immunoreactivity is widespread in the autonomie neurons and sensory neurons of the rat. Neurosci. 47:673-684.
34. Wotherspoon, G., Lopez-Costa, J. J., Michael, G. J., and Priestley, J. V. 1997. Constitutive expression of calmodulin-binding phosphoprotein GAP-43 in rat serotonergic and noradrenergic cell groups which project to the spinal cord. Neurochem. Res. 22:985-993.
35. De la Monte, S. M., Ng, S-C., and Hsu, D. W. 1995. Aberrant GAP-43 gene expression in Alzheimer's disease. Am. J. Pathol. 147:934-946.
36. Mitsumoto, H., and Gambetti, P. 1986. Impaired slow axonal transport in wobbler mouse motor neuron disease. An. Neurol. 19:36-43.
37. Kapfhammer, J. P., and Schwab, M. E. 1994. Inverse patterns of myelination and GAP-43 expression in the dault CNS: neurite growth inhibitors as regulators of neuronal plasticity ?. J. Comp. Neurol. 340:194-206.
38. Federoff, H. J., Grabczyk, E., and Fishman, M. C. 1988. Dual regulation of GAP-43 gene expression by nerve growth factor and glucocorticoids. J. Biol. Chem. 263:19290-19295.
39. Chao, H. M., Spencer, R. L., Sakai, R. R., and McEwen, B. S. 1992. The expression of growth-associated protein GAP-43 mRNA in the rat hippocampus in response to adrenalectomy and aging. Mol. Cell. Neurosci. 3:529-535.
40. Metzinger, L., Passaquin, A-C., Vernier, A., Thiriet, N., Warter, J-M., and Poindron, P. 1992. Lazaroids enhance skeletal myogenesis in primary cultures of dystrophin-deficient mice. J. Neurol. Sci. 126:138-145.
41. Dun, N. J., Dun, S. L., Wu, S. Y., Forsterman, U., Schmidt, H. H. H. W., and Tseng, L. F. 1993. Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord. Neurosci. 54:845-857.
42. Wu, W. 1993. Expression of nitric oxide synthase (NOS) in injured CNS neurons as shown by histochemistry for NADPH-diaphorase. Exp. Neurol. 120:153-159.
43. Choi, D. W. 1993. Nitric oxide: foe or friend to the injured brain ?. Proc. Natl. Acad. Sci. USA 90:9741-9743.
44. Buttery, L. D. K., and Polak, J. M. 1995. Localization of nitric oxide synthase: alterations in disease. Current Diag. Pathol. 2:111-121.
45. Resink, A., Dawson, V. L., and Dawson, T. D. 1996. Nitric oxide synthase inhibitors. CNS Drugs 6:351-367.
46. Nathan, C., and Xie, Q-W. 1994. Nitric oxide synthases: roles, tolls and controls. Cell 78:915-918.
47. Krieger, C., Perry, T. L., Hanse, S., Mitsumoto, H., and Honoré, T. 1992. Excitatory amino acid receptor antagonist in murine motoneuron disease (the wobbler mouse). Can. J. Neurol. 19:462-465.
48. Dawson, V. L., and Dawson, T. M. 1996. Nitric oxide in neuronal degeneration. FASEB J. :33-40.
49. Regan, R. F., and Panter, S. S. 1995. Traumatic neuronal injury in cortical cell culture is attenuated by 21-aminosteroids. Brain Res. 682:144-150.
50. Smith, D. H., Gennarelly, T. A., and Mcintosh, T. K. 1995. The potential of 21-aminosteroids (Lazaroids) as neuroprotective therapies in CNS injury. CNS Drugs 3:159-164.
51. Feasby, T. E., Hahn, A. F., Lovgren, D., and Wilkie, L. 1994. Lewis rat EAN is suppressed by the 21-aminosteroid tirilazad mesylate (U-74006F). Neuropathol. Applied Neurobiol. 20:384-391.
52. Braughler, J. M., Hall, E. D., Jacobsen, E. J., McCall, J. M., and Means, E. D. 1989. The 21-aminosteroids: potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia. Drugs of the Future 14:143-152.
53. Hayashi, T., Ishikawa, T., Yamada, K., Kuzuya, M., Naito, M., Hidaka, H., and Iguchi, A. 1994. Biphasic effect of estrogen on neuronal constitutive nitric oxide synthase via Ca2+-calmodulin dependent mechanism. Biochem. Biophys. Res. Commun. 203:1013-1019.
54. Fishman, M. 1996. GAP-43: putting constrains on neuronal plasticity. Persp. Dev. Neurobiol. 4:193-198.